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ABSTRACT
Objectives: Approximately 80% of patients complain of
various symptoms immediately after laparoscopic Nissen
fundoplication. These symptoms typically are treated
medically without an extensive evaluation to identify the
cause. We reviewed our experience of laparoscopic Nis-
sen fundoplication to determine the course of postopera-
tive symptomatology in our patient population, and
present a rational approach to this problem.
Methods: Over a 10-year period, 628 patients underwent
primary laparoscopic Nissen fundoplication for gastro-
esophageal reflux disease; patients were evaluated with a
standard set of questions for postoperative gastrointestinal
complaints. Three- and 6-month follow-up data were
compared by using the chi square test.
Results: One-year follow-up data were available for 615
patients (98%). All of these patients had symptoms during
the first 3 postoperative months. Early satiety (88%), bloat-
ing/flatulence (64%), and dysphagia (34%) were the most
common; however, 94% of patients had resolution of their
symptoms by the 1-year follow-up visit, and most had
resolved after 3 months. Patients with persistent reflux or
dysphagia after 3 months typically had an anatomic failure
of the operation.
Conclusions: Most patients who have undergone lapa-
roscopic Nissen fundoplication for gastroesophageal re-
flux disease will have gastrointestinal complaints during
the initial 3 postoperative months. Nearly all of these
patients will have resolved their symptomatology after 3
months. Those with persistent symptoms after 3 months
warrant evaluation for operative failure.
Key Words: Gastroesophageal reflux disease, Minimally
invasive surgery, Laparoscopic Nissen fundoplication,
Dysphagia, Postoperative symptoms.
INTRODUCTION
A popular option for the surgical management of gastro-
esophageal reflux disease is minimally invasive Nissen
fundoplication. Similar to that of other “nonamputative”
procedures, the successful outcome of a Nissen fundopli-
cation is dependent on a technically precise operation in
a well-selected patient. Currently, the technical modifica-
tion of Donahue et al (ie, “floppy” fundoplication)1 to the
Nissen procedure is in common use, although precise
statistics are not available. The floppy Nissen fundoplica-
tion is favored for the treatment of gastroesophageal re-
flux disease because this procedure maximizes reflux con-
trol while minimizing dysphagia. Minimally invasive
Nissen fundoplication was first described in 1991.2 Subse-
quently, the indications, preoperative evaluation, techni-
cal aspects, and outcome for minimally invasive Nissen
fundoplication have been well described.1,3–7
One observation we have made in our own series of
minimally invasive Nissen procedures is the routine
occurrence of temporary postoperative gastrointestinal
complaints (this observation also has been made by
others8–10). We also have observed that many patients are
treated by their referring physicians for these temporary
postoperative gastrointestinal symptoms, perhaps too ag-
gressively, as noted by others.11 We therefore wanted to
identify the incidence, severity, and duration of these
symptoms in our patient population to provide prospec-
tive patients with quantitative data on this issue. We found
that the vast majority of postoperative gastrointestinal
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SCIENTIFIC PAPERcomplaints after minimally invasive Nissen fundoplication
are temporary, and do not require prolonged (if any)
medical treatment.
METHODS
Over a 10-year period, 628 patients underwent laparo-
scopic Nissen fundoplication under the supervision of the
first author (CTF). The typical indication for fundoplica-
tion in this series was gastroesophageal reflux disease; this
diagnosis required objective evidence that usually was in
the form of esophagitis on endoscopy or a positive am-
bulatory pH study, or both.12 The technique of “floppy”
Nissen fundoplication has been described.1,13,14 The com-
ponents of this procedure that we believe to be critical
include1 circumferential esophageal mobilization result-
ing in an adequate length (3 cm to 5 cm) of intraabdomi-
nal esophagus2; closure of the diaphragmatic crura with
posterior (and occasionally anterior) cruroplasty over a
large (56 F to 60 F) bougie3; fundal mobilization with
division of the short gastric vessels4; a short (about 2 cm),
floppy 360° wrap that utilizes the fundus only (not the
gastric body); and5 fixation of the wrap to the anterior
crural arch (but not to the esophagus itself). In addition,
we used prosthetic reinforcement of the cruroplasty when
faced with a large hiatal defect; this practice reduced hiatal
hernia recurrence in a randomized trial.15
Postoperative follow-up was performed in the office of
the supervising surgeon at 1 week, then at 1, 3, and 6
months, and then yearly. Postfundoplication dietary re-
strictions included avoidance of carbonated beverages
and gas-producing food for 3 months, and eliminating
meat for 1 month after surgery. In general, the patients
had no dietary restrictions after 3 months. At each fol-
low-up visit, each patient was queried regarding early
satiety, dysphagia, odynophagia, hiccups, diarrhea, nau-
sea, bloating/flatulence, and constipation (Table 1). The
incidence of each symptom during different postoperative
periods was compared with the Fischer exact or chi
square test; the level of significance was P0.05.
RESULTS
Twelve-month follow-up data were available in 615/628
patients (98%). Recurrent reflux (ie, a failed procedure)
occurred in 16 patients (2.5%); in 14 of these, the failure of
the procedure was evident by the 6-month follow-up visit.
Exclusion of the above 16 patients (ie, those with reflux
recurrent at 3 months postoperatively) left 599 patients
for analysis. During the first 3 postoperative months, 100%
of these patients had at least 1 gastrointestinal complaint;
early satiety (88%), bloating/flatulence (64%), and dys-
phagia (34%) were the most common symptoms (Table
2). The vast majority of these symptoms were resolved
Table 1.
Questions Administered at Each Follow-up Visit
12
1. Do you have difficulty swallowing? If so, does the
difficulty seem to be in the upper or lower chest? Is the
difficulty with solids or liquids or both?
2. Do you experience heartburn? How often?
3. Do you experience pain with swallowing?
4. Do you experience chest pain when swallowing?
5. Do you vomit? How often?
6. Do you experience nausea?
7. Do you have dry heaves, hiccups, or both?
8. Do you regurgitate liquids, solids, or both?
9. Do you have a morning cough?
10. Do you have difficulty breathing or asthma?
11. Do you have voice hoarseness?
12. Do you have bloating, or flatulence (gas from below), or
both?
13. Do you get full with small portions of food?
14. Do you have diarrhea? How often?
15. Do you have constipation?
16. Do you have indigestion? How often?
Table 2.
Gastrointestinal Symptoms 0 to 3 and 3 to 12 Months After
Minimally Invasive Nissen Fundoplication*
Symptom Number of Patients With
Symptom During Indicated
Postoperative Period
P Value
0–3 months
(%)
3–12 months
(%)
Early satiety 527 (88%) 0 0.01
Bloating/flatulence 385 (64%) 21 (4%) 0.01
Dysphagia 201 (34%) 5 (0.8%) 0.01
Constipation 44 (7%) 0 0.01
Diarrhea 52 (9%) 7 (1%) 0.01
Odynophagia 18 (3%) 0 0.01
Nausea 29 (5%) 0 0.01
Hiccups 27 (4%) 0 0.01
*Comparison of the incidence between the 2 periods was per-
formed with either the Fisher exact or chi square test.
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(data on the precise time of symptom resolution are not
available). In the 3-month to 12-month postoperative in-
terval, the incidence of gastrointestinal complaints in the
599 patients decreased markedly; specifically, 94% of
these patients did not report symptoms during this period
(Table 2).
The symptoms of bloating and flatulence (n  21), dys-
phagia,5 and diarrhea7 were persistent in 33 patients be-
yond the third postoperative month (Table 2). Of note, 5
patients with persistent flatulence or diarrhea carried a
preoperative diagnosis of irritable bowel syndrome. Up-
per endoscopy and barium radiography were performed
in the 5 patients with persistent postoperative dysphagia;
the associated causes included a slipped fundoplication
(n2), and a tight cruroplasty, a tight wrap, and no iden-
tifiable cause (n1 each). Eleven patients with bloating
and flatulence and 4 patients with diarrhea were evaluated
with upper endoscopy, colonoscopy, and Clostridium dif-
ficile testing; none of this evaluation identified causative
pathology.
DISCUSSION
Up to 62% of patients who have undergone an antireflux
procedure may be treated chronically with antireflux med-
ication in the postoperative period16; such postoperative
antireflux treatment is given in some cases without docu-
mentation of reflux.17 We have documented a high inci-
dence (100% of our series) of temporary postoperative
gastrointestinal complaints after laparoscopic Nissen fun-
doplication. Other authors also have observed similar
rates of temporary complaints after an antireflux proce-
dure.6,18 It has been our experience that these postoper-
ative gastrointestinal complaints resolve by 3 months in
over 90% of the patients. Interestingly, it has been shown
that the accuracy of postoperative symptoms in predicting
objective reflux (as measured by 24-hr pH monitoring) is
poor, and that some asymptomatic patients actually may
have subclinical reflux after a “successful” fundoplica-
tion.11 We would argue that the more relevant observation
is that laparoscopic antireflux surgery, when performed
by experienced surgeons, results in a long-term clinical
success rate of 90%.4,5
Postoperative symptoms like bloating, flatulence, and dys-
phagia can be minimized with the avoidance of carbon-
ated beverages, gas-producing foods (eg, beans), and
coarse substances (eg, red meat). Patients may still have
the sensation of heartburn after a successful antireflux
procedure. This is not necessarily indicative of recurrent
reflux, but possibly due to irritation of the esophageal
mucosa secondary to drinking a relatively caustic bever-
age, such as citrus juice or alcohol. These beverages also
should be avoided for several months so that the patient’s
esophagitis has a chance to resolve. If gastrointestinal
symptoms occur during the first 3 months after fundopli-
cation, our evidence suggests that the symptoms resolve
in the vast majority of patients. Chronic medication is not
required. The only treatment needed at this point is pa-
tient education and reassurance. If a patient has symptoms
that persist beyond the 3 months postoperatively, how-
ever, an endoscopic and contrast fluoroscopic evaluation
should be undertaken.
Other than recurrent reflux, the most common persistent
symptom requiring intervention in our series was dyspha-
gia, which happened in 1% of our patients. The cause of
postoperative dysphagia is multifactorial,10 including fac-
tors such as an undiagnosed motility disorder (eg, acha-
lasia), a wrap failure (eg, slippage, overly tight wrap or
cruroplasty, or corpus wrap), retroperitoneal hematoma,
or peptic stricture. Treatment for dysphagia is specific to
its cause, such as revisional surgery for wrap failure.19–22
Persistent bloating/flatulence may be treated with sime-
thicone and dietary modification; further treatment can
consist of speech therapy to retrain/control swallowing
frequency.23 The cause of persistent diarrhea often is not
clear; vagal injury often is implicated.24 The treatment of
persistent diarrhea includes antidiarrheals; further evalu-
ation of the lower gastrointestinal tract (for irritable bowel
syndrome, pseudomembranous colitis, etc) might be con-
sidered.
CONCLUSION
Since 1995 laparoscopic Nissen fundoplication has been
shown to be safe and effective therapy for gastroesopha-
geal reflux disease. Although many patients will have
gastrointestinal complaints during the first 3 months after
laparoscopic Nissen fundoplication, the vast majority of
these symptoms will resolve and do not require chronic
treatment. We suggest patient education and reassurance
for the complaints that come up during this initial period,
and reserve further evaluation for symptoms that persist
beyond 3 months.
References:
1. Donahue PE, Samelson S, Nyhus LM, Bombeck CT. The
floppy Nissen fundoplication. Effective long-term control of
pathologic reflux. Arch Surg. 1985;120(6):663–668.
2. Dallemagne B, Weerts JM, Jehaes C, et al. Laparoscopic
JSLS (2006)10:39–42 41Nissen fundoplication: preliminary report. Surg Laparosc En-
dosc. 1991;1(3):138–143.
3. Frantzides CT, Richards C. A study of 362 consecutive lapa-
roscopic Nissen fundoplications. Surgery. 1998;124(4):651–654;
discussion 654–655.
4. Carlson MA, Frantzides CT. Complications and results of
primary minimally invasive antireflux procedures: a review of
10,735 reported cases. J Am Coll Surg. 2001;193(4):428–439.
5. Fuchs KH, Breithaupt W, Fein M, Maroske J, Hammer I.
Laparoscopic Nissen repair: indications, techniques and long-
term benefits. Langenbecks Arch Surg. 2005;390:197–202. Epub
2004 Jul 3.
6. Anvari M, Allen C. Five-year comprehensive outcomes eval-
uation in 181 patients after laparoscopic Nissen fundoplication.
J Am Coll Surg. 2003;196(1):51–57; discussion 57–58; author
reply 58–59.
7. Booth MI, Jones L, Stratford J, Dehn TC. Results of laparo-
scopic Nissen fundoplication at 2–8 years after surgery. Br J
Surg. 2002;89(4):476–481.
8. Kamolz T, Bammer T, Pointner R. Predictability of dysphagia
after laparoscopic nissen fundoplication. Am J Gastroenterol.
2000;95(2):408–414.
9. Rantanen TK, Salo JA, Salminen JT, Kellokumpu IH. Func-
tional outcome after laparoscopic or open Nissen fundoplica-
tion: a follow-up study. Arch Surg. 1999;134(3):240–244.
10. DeMeester TR, Bonavina L, Albertucci M. Nissen fundopli-
cation for gastroesophageal reflux disease. Evaluation of primary
repair in 100 consecutive patients. Ann Surg. 1986;204(1):9–20.
11. Khajanchee YS, O’Rourke RW, Lockhart B, et al. Postoper-
ative symptoms and failure after antireflux surgery. Arch Surg.
2002;137(9):1008–1013; discussion 1013–1014.
12. Frantzides CT, Carlson MA, Madan AK, et al. Selective use of
esophageal manometry and 24-Hour pH monitoring before lapa-
roscopic fundoplication. J Am Coll Surg. 2003;197(3):358–363;
discussion 363–364.
13. Richardson WS, Hunter JG. Laparoscopic floppy Nissen fun-
doplication. Am J Surg. 1999;177(2):155–157.
14. Frantzides CT, Carlson MA. Paraesophageal Herniation. In:
Baker RJ, Fischer JE, eds. Mastery of Surgery. Vol. 1. Philadel-
phia: Lippincott Williams & Wilkins; 2001;721–736.
15. Frantzides CT, Madan AK, Carlson MA, Stavropoulos GP. A
prospective, randomized trial of laparoscopic polytetrafluoroeth-
ylene (PTFE) patch repair vs simple cruroplasty for large hiatal
hernia. Arch Surg. 2002;137(6):649–652.
16. Spechler SJ, Lee E, Ahnen D, et al. Long-term outcome of
medical and surgical therapies for gastroesophageal reflux dis-
ease: follow-up of a randomized controlled trial. JAMA. 2001;
285(18):2331–2338.
17. Galvani C, Fisichella PM, Gorodner MV, et al. Symptoms are
a poor indicator of reflux status after fundoplication for gastro-
esophageal reflux disease: role of esophageal functions tests.
Arch Surg. 2003;138(5):514–518; discussion 518–519.
18. Swanstrom L, Wayne R. Spectrum of gastrointestinal symp-
toms after laparoscopic fundoplication. Am J Surg. 1994;167(5):
538–541.
19. Frantzides CT, Carlson MA. Laparoscopic redo Nissen fundo-
plication. J Laparoendosc Adv Surg Tech A. 1997;7(4):23523–9.
20. Granderath FA, Kamolz T, Schweiger UM, Pointner R. Lapa-
roscopic refundoplication with prosthetic hiatal closure for re-
current hiatal hernia after primary failed antireflux surgery. Arch
Surg. 2003;138(8):902–907.
21. Watson AJ, Krukowski ZH. Revisional surgery after failed
laparoscopic anterior fundoplication. Surg Endosc. 2002;16(3):
392–394.
22. Serafini FM, Bloomston M, Zervos E, et al. Laparoscopic
revision of failed antireflux operations. J Surg Res. 2001;95(1):
13–18.
23. Azpiroz F, Serra J. Treatment of excessive intestinal gas. Curr
Treat Options Gastroenterol. 2004;7(4):299–305.
24. Ukleja A, Woodward TA, Achem SR. Vagus nerve injury with
severe diarrhea after laparoscopic antireflux surgery. Dig Dis Sci.
2002;47(7):1590–1593.
Postoperative Gastrointestinal Complaints After Laparoscopic Nissen Fundoplication, Frantzides CT et al
JSLS (2006)10:39–42 42